Evaluation of Synergetic Anticancer Activity of Berberine and Curcumin on Different Models of A549, Hep-G2, MCF-7, Jurkat, and K562 Cell Lines

Table 5

Average percent activity of 95% Curcumin.

Concentration in mg/mL	Average percent activity of 95% Curcumin
	Hep-G2	A549	MCF-7	Jurkat	K562
1.250	87.281	60.572	91.339	23.566	164.271
0.313	73.164	67.627	51.388	77.057	88.809
0.078	97.774	63.016	87.008	104.489	78.747
0.020	43.297	40.120	49.814	47.257	62.320
0.005	6.348	1.291	−22.897	33.915	81.211
0.001	−0.474	−6.756	−39.039	15.337	−8.316